scispace - formally typeset
A

Alexander Ploss

Researcher at Princeton University

Publications -  153
Citations -  10377

Alexander Ploss is an academic researcher from Princeton University. The author has contributed to research in topics: Hepatitis C virus & Virus. The author has an hindex of 46, co-authored 134 publications receiving 8935 citations. Previous affiliations of Alexander Ploss include Imperial College London & Bill & Melinda Gates Foundation.

Papers
More filters
Journal ArticleDOI

Human occludin is a hepatitis C virus entry factor required for infection of mouse cells

TL;DR: It is shown that human occludin (OCLN) is an essential HCV cell entry factor that is able to render murine cells infectable with HCVpp and the identification of OCLN as a new HCV entry factor further highlights the importance of the tight junction complex in the viral entry process.
Journal ArticleDOI

Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro

TL;DR: It is reported here that HCVcc strain FL-J6/JFH can establish long-term infections in chimpanzees and in mice containing human liver grafts, and virus recovered from these animals was highly infectious in cell culture, demonstrating efficient ex vivo culture of HCV.
Journal ArticleDOI

A genetically humanized mouse model for hepatitis C virus infection

TL;DR: It is demonstrated that HCV can be blocked by passive immunization, as well as showing that a recombinant vaccinia virus vector induces humoral immunity and confers partial protection against heterologous challenge.
Journal ArticleDOI

Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus

TL;DR: The mAb panel will be useful for the design and development of vaccine candidates to elicit broadly neutralizing antibodies to HCV, and has an exceptionally broad neutralizing activity toward diverse HCV genotypes and protects against heterologous HCV challenge in a small animal model.